Stanton J. Rowe, Edwards Lifesciences Corporation on Entrepreneurship

Featuring Stanton J. Rowe
Corporate Vice President, Advanced Technology and Chief Scientific Officer
Edwards Lifesciences Corporation

Location: McDonnell Douglas Engineering Auditorium
Free and open to the public

For a complete listing of Entrepreneurship Seminar Series guest speakers, please visit http://www.eng.uci.edu/events/entseminars.

About the Speaker:
Stanton J. Rowe is responsible for all early stage development work within Edwards Lifesciences Corporation, as well as Discovery, the efforts to identify external technologies or companies which add value to Edwards. These include efforts to development a range of minimally invasive and percutaneous approaches to heart valve replacement or repair. He previously served as President and CEO of Percutaneous Valve Technologies Inc., which was acquired by Edwards in January 2004. 

Prior to PVT, which he helped to found in 1999, Rowe was corporate vice president of business development and strategic planning for Datascope Corp. Prior to this, he was vice president of business development for Johnson & Johnson’s Interventional Systems Division (JJIS), and responsible for the company’s coronary stent development efforts.  

At JJIS, and the related Cordis Corporation, Rowe held a variety of positions with increasing levels of responsibility, including heading the company’s business development, advanced technology, worldwide clinical research, and marketing groups. Rowe joined Cordis after having held several positions in product management for various medical device companies.  He holds a bachelor’s degree from the University of Alabama.  He also sits on the board of directors of both Remon Medical Ltd. and Biomerix Corp.